As of 2026-03-29, 明治製藥 (Meiji)'s data on the DeepSeek platform in the 医疗保健 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 明治製藥 (Meiji)'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
明治製藥 (Meiji)'s Mention Rate is 0.00%, lower than 0.6% of competitors
明治製藥 (Meiji)'s First Mention is 0.00%, lower than 0.9% of competitors
明治製藥 (Meiji)'s Preferred Rate is 0.00%, lower than 100.0% of competitors
明治製藥 (Meiji)'s Positive Rate is 0.00%, lower than 8.9% of competitors
明治製藥 (Meiji)'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| PProbi | 0% | 0% | 0% | 0% | 0% | View Details |
| 强强生 (Johnson & Johnson) | 0% | 0% | 0% | 0% | 0% | View Details |
| 辉辉瑞 (Pfizer) | 0% | 0% | 0% | 0% | 0% | View Details |
| 健健安喜 (GNC) | 0% | 0% | 0% | 0% | 0% | View Details |
| 澳澳佳宝 (Blackmores) | 0% | 0% | 0% | 0% | 0% | View Details |
| 肝肝益莱 (Livereliv) | 0% | 0% | 0% | 0% | 0% | View Details |
| 明明治製藥 (Meiji) (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
